Get started

Consolidation

Divis Labs (Bullish stance)Divis Labs: Sector: Pharma and Biotechnology Industry: Pharma Divis Laboratories (Weekly): 1. Double Bottom 2. Breakout of Double Bottom 3. Positive Crossover of 5,13 Weeks Exponential Moving Average Daily: 1. RSI Bullish Divergence and Double Bottom Breakout 2. Trendline Breakout 3. Good to buy above consolidation breakout (closing above 4590) 4. Positive crossover of 5,13 Days Exponential Moving Average 5. Trading above 200 Days Exponential Moving Average Addl Points: 1. FII/FPI have decreased holdings from 19.30% to 18.45% in Mar 2022 qtr 2. Mutual Funds have increased holdings from 13.35% to 13.68% in Mar 2022 qtr. Note: 1. The above analysis is just for educational purpose.
NSE:DIVISLABLong
by deeptinseth
Anand Rathi Breakout after good quarterly numbers1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or daily RSI closing below 40 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Weekly tailing tops with high volume c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after posting quarterly sales growth of 60%, quarterly profit growth of 257%, TTM sales growth of 53% and TTM profit growth of 181%, NSE:ANANDRATHI has given a high volume breakout today. Buy with a stop at rupees 610.
NSE:ANANDRATHILong
by akashbothra
Ester Breakout after Rating Updates 1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or daily RSI closing below 40 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Weekly tailing tops with high volume c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop After a consolidation since May 2021, NSE:ESTER has given a high volume breakout today. Buy with a stop at Rs.151. Other fundamentals: 1. In the first nine months of fiscal 2022, the company generated revenue of Rs 1,018 crore with operating margin of 17.7%, against Rs 696 crore and 25.3%, respectively, in the corresponding period of the previous fiscal. High operating margins during last fiscal has now been normalized in current fiscal. Improvement in operating performance is driven by continuation of favourable demand-supply dynamics in the packaging films business and maturing of products. 2. The engineering plastics and specialty polymers segments have also seen healthy improvement in demand over the past nine months. Therefore, despite the expected decline of margin in packaging films business, the overall operating profit before depreciation, interest and tax (OPBDIT) margin of EIL is expected to sustain around 15% over the medium term, benefitting from a diverse product portfolio. 3. Product mix and diversification should improve as the company is adding capacities of value-added products, specialty polymers and engineering plastics for capital expenditure (capex) of Rs 225 crore, which is likely to be completed in fiscal 2023. Furthermore, revenue of the packaging films business is expected to improve with the new greenfield BOPET (biaxially-oriented polyethylene terephthalate) line (48,000 tonne per annum in Telangana) expected to be commissioned by October 2022. The progress of the project will remain a monitorable. 4. Average Roe for last three and five years above 15%. 5. Five year CAGR sales growth at 5% and profit growth at 93%. 6. Company has been maintaining a healthy dividend payout of 18.11%. 7. Debt to equity at 0.39 (less than 1 is good), Interest Coverage at 9.54 (greater than 3 is good), Current ratio at 2.05 (greater than 1.5 is good), FCF to CFO at 59%.
NSE:ESTERLong
by akashbothra
Ganesh Benzoplast Breakout 1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or daily RSI closing below 40 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Weekly tailing tops with high volume c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop After a consolidation since 2017, BSE:GANESHBE has given a high volume breakout on Friday. Buy with a stop at Rs.105. Other fundamentals: 1. According to a news report published on 11th March, Ganesh Benzoplast Limited along with Singapore based Golden Agri International Enterprises Pte. Ltd., K N Agri Resources Ltd and other investors, through– Bluebrahma Clean Energy Solutions Pvt Ltd. – has ventured into production of Ethanol and Extra Neutral Alcohol. ( www.livemint.com ) 2. 10 year sales CAGR at 10% and profit CAGR at 75%. 3. Debt to equity at 0.18 (less than 1 is good), Interest Coverage at 15.8 (greater than 3 is good), FCF to CFO at 60%. 4. From 287 crore in 2012, debt came down to 45 crores in September 2021. 5. Promoter holding has increased by 1.27% over the last quarter.
BSE:GANESHBELong
by akashbothra
Uflex breakout 1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or daily RSI closing below 40 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Weekly tailing tops with high volume c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop After a consolidation since October 2021, NSE:UFLEX has given a breakout today. Buy with a stop just below Rs.620.
NSE:UFLEXLong
by akashbothra
Ruchira papers break out1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula: - Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after a quarterly sales and profit growth of 27% and 1365% respectively and TTM sales growth of 48% and TTM profit growth of 730%, NSE:RUCHIRA gave a high volume break out today from an 8-month long consolidation zone. Buy with a stop around rupees 92. Other fundamental: 1. According to stock market experts, paper mills are least affected by recent global triggers like Ukraine-Russia war, soaring crude oil price and other commodity prices ascending to its multi-month highs. In fact, unlock theme has fueled demand for papers as schools and other educational institutions are reopening now. Recently pulp and waste paper prices in the international markets have gone up that may give margin benefits to the paper mills in upcoming quarters. 2. The Company has a manufacturing unit in Sirmaur, Himachal Pradesh. The current installed capacity stands at 400 TPD. This includes 250 tonnes per day of Kraft Paper and 150 tonnes per day of writing and printing paper. It also has a 8.1 MW captive power plant at its Kala Amb facility which helps source 100% of the power requirement of writing & printing paper from within. 3. The Co launched white copier paper and bleached kraft, which is used for the manufacture of carry bags with quality equivalent to the imported grade of bleached kraft in the market. The newly launched product constituted 12% of the revenues from writing and printing papers in FY21. 4. The Co is focusing on repayment of its long-term borrowings in FY22 and derisking of the balance sheet. 5. Stock is trading at 0.98 times its book value. 6. Promoter holding has increased by 1.36% over last quarter. 7. Debt to equity at 0.22 (less than 1 is good), Interest Coverage at 6.84 (greater than 3 is good), Current ratio at 1. 63% (greater than 1.5 is good). 8. Sector leader in terms of one month and six months' return.
NSE:RUCHIRALong
by akashbothra
BSOFT breakout1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or daily RSI closing below 40 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Weekly tailing tops with high volume c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after a consolidation since February 2022, NSE:BSOFT has given a break out today. It is a buy with a stop just below Rs.465. Other fundamentals: 1. It is part of The CK Birla Group, Birlasoft, comprising over 10,000 plus professionals. 2. There has been an acceleration in Birlasoft’s participation in large deals, from the signing of multiple transformational projects, including a multi-services deal worth US$ 242 M TCV, with US-based healthcare major Invacare Inc. The Invacare deal is the largest deal in Birlasoft’s history. 3. In FY19, Birlasoft Ltd merged and amalgamated with KPIT Technologies Limited. The merger brought together with skill sets from both businesses. Birlasoft Ltd had strengths primarily in the non-ERP Digital businesses like CRM, BI & Data Analytics, and Application Development, while KPIT IT Services possessed core strengths on the Enterprise Software Solutions like Oracle, JD Edwards, SAP, Infor, etc and capabilities in Digital Transformation services. Birlasoft has created a niche in the mid-tier IT services companies following the merger with KPIT. 4. With successful integration with KPIT Technologies Limited in FY20, FY21 was the second year of operations, wherein the company witnessed stabilization and growth post restructuring. During FY21, the company sharpened its focus to build key business verticals through a micro-vertical strategy, made investments on major business partnerships to expand capabilities and increased focus on its top customers for effective client mining, thereby leading to improved deal wins and increased revenue per account. Going forward, with continued focus on such strategic initiatives are expected to yield sustained growth in operations and profitability for the company. 5. Company is almost debt free. 6. Company has been maintaining a healthy dividend payout of 24.62%. 7. Debtor days have improved from 79.00 to 53.20 days. 8. Debt to equity at 0.05 (less than 1 is good), Interest Coverage at 48.1 (greater than 3 is good), Current ratio at 3.60 (greater than 1.5 is good), FCF to CFO at 64.2%.
NSE:BSOFTLong
by akashbothra
Southern Petrochem break out1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after quarter sales growth of 15%, quarter profit growth of 832%, and TTM sales growth of 15% and TTM profit growth of 318%, NSE:SPIC give a high volume break out on 21st March 2022 after a consolidation since July 2021. Today it came down to the previous resistance zone at Rs.68-69 and gave a bounce back. Buy with a stop just below Rs. 68. Other fundamentals: 1. The company has reduced debt from 408 crores in March 2020 to 104 crores in September 2021. 2. The company has delivered good profit growth of 43.79% CAGR over last 5 years.
NSE:SPICLong
by akashbothra
Suven Pharma high volume breakout1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after a consolidation since August 2021 NSE:SUVENPHAR gave a high volume break out today. It is a buy with a stop around Rs. 544. Other fundamentals: 1. SPL engages in NCE molecule development and supply of intermediates. This is a high-value-add, high-margin business. SPL supplies intermediates for four molecules addressing rheumatoid arthritis, diabetes, depression and women’s health. This segment makes up 78% of revenues. The company has a strong order book with new clients being consistently added. Most clients are the Big Pharma companies in Europe and the US. The company is looking to shift from Intermediate to API manufacturing and is in discussion with clients regarding this. The company has stated that it has the facilities for API manufacturing. 2. The Company is supplying intermediates – derived out of its CDMO competence – for two specialty chemical products (agrochemical) to large global conglomerates. In this segment, the company is currently working on two molecules with a new molecule to be developed next year. 3. The company has planned for a capex of Rs 600cr, a large part of which will be utilized in facility upgradation, technology enhancement and relocation spread over 3 years. This will be over and above the current ongoing capex of Rs 320cr spent over FY19-21. The capex would be mainly used for modernization of manufacturing facilities, relocation of R&D facilities and acquisition of new technologies. The company has already spent a Capex of Rs.94cr in 9MFY21 to expand its existing manufacturing facilities. 4. Suven Pharma is associated with more than 70 global companies. The company has an established market position in the CRAMS segment and is among the top five players in India who supply high-end intermediaries to innovators. Company is getting repeat business owing to long standing relationships with MNC companies. The industry has high entry barriers, needs deep technical expertise and is a sticky business. 5. Suven Pharma Inc. is a wholly owned subsidiary of SPL. It is a Special Purpose Vehicle created to invest in Rising Pharma Holdings Inc. Suven Pharma Inc. has 25 % holding in Rising Pharma Holdings Inc. Rising Pharma Holdings Inc. is a New Jersey, USA based pharmaceutical company focused on developing generic pharmaceuticals products in various therapeutic segments. 6. Company has reduced debt. 7. Debtor days have improved from 76.94 to 37.01 days. 8. Since June 2020 FII steak increased from 3.55 to 8.25. 9. Debt to equity at 0.10 (less than 1 is good), Interest Coverage at 104 (greater than 3 is good), Current ratio at 3.19 (greater than 1.5 is good).
NSE:SUVENPHARLong
by akashbothra
TTK Healthcare break out 1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after a quarter sales growth of 18%, quarter profit growth of 58%, TTM sales growth of 30% and TTM profit growth off 39%, NSE:TTKHLTCARE has given a high-volume breakout today after a consolidation since July 2021. One can buy with a stop at Rs. 798. Other fundamentals: - 1. TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India. 2. The company's pharmaceuticals business include products for both human and veterinary use :- a. Ethical Products/ Pharma Division - The company's ethical pharma business deals in pharmaceutical formulations both herbal and allopathic, in various therapeutic segments and food supplements. It has a network of 1000+ sales team and a network of 3000+ distributors. b. Animal Welfare Division - The company sells a wide range of animal pharma products under this division. Its portfolio includes feed supplements, fertility inducers, antibiotics, cocktail enzymes, etc. Its network is spread over 9,000 veterinarians across India. 3. The company's consumer products business comprises of marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good home range of scrubbers, air freshners, etc. The company's brand 'Woodward's Gripe Water' is one of the oldest FMCG brands worldwide and is a market leader in the Indian colic market. It has been marketed in India since 1928. Its distribution network includes 27 warehouses, 2,600+ distributors, 650+ frontline sales team and a reach to 4 lakh+ outlets across India. 4. The company is one of the largest manufacturers of extruded products (papad) in India which are B2B and export customers and are also marketed in selected markets in India. It sells its products under the brand name 'Fryums'. 5. Company is one of the key players in the Indian Condom Industry. It is involved in manufacture and marketing of male contraceptives and other allied products. It sells products under its own brand 'SKORE'. 6. The company's medical devices business is divided into 2 divisions :- a. Orthopedics Division- The company's orthopedics division offers joint replacement portfolio which includes a variety of components, types and sizes. It has technical collaborations with various companies situated in USA, Germany, UK & Italy for the orthopedics business. b. Heart Valve Division - The division manufactures and distributes heart valve prosthesis in India. It manufactures all 3 components for heart valve i.e. Frame, Disc & sewing ring. It has a manufacturing capacity of 20,000 heart valves p.a. 7. Presently, the company owns and operates 8 manufacturing facilities in India in Karnataka, Tamil Nadu, Puducherry, Kerala, and Rajasthan. It has adopted an outsourcing model for manufacturing most of its products, except for foods, medical and protective devices divisions. 8. Promoter Holding at 75% (greater than 45% is good) 9. Dividend Yield at 0.67% (consistent dividend payer since 2010) 10. Debt to equity at 0.02 (less than 1 is good), Interest Coverage at 17.3 (greater than 3 is good), Current ratio at 1.99% (greater than 1.5 is good), FCF to CFO at 59% (company won’t have to raise debt for expansion)
NSE:TTKHLTCARELong
by akashbothra
Delta Corp breakout1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after a quarter sales growth of 104%, quarter profit growth of 460%, TTM sales growth off 57% and TTM profit growth of 292%, NSE:DELTACORP gave a break out yesterday with high volumes after a consolidation since October 2021. Today the share price dropped below the previous support point of Rs.300 and bounced back. It is a buy with a stop just below Rs. 283, or it is a buy above Rs. 319 with a stop just below Rs. 297. Other fundamentals: 1. Debt to equity at 0.00 (less than 1 is good), Interest Coverage at 20.6 (greater than 3 is good), Current ratio at 4.08 (greater than 1.5 is good). 2. Delta Corp Ltd is the largest gaming company in India and they are the only listed company in the casino gaming with 2000+ live gaming positions. They have managed to capture 55% of market share in the organized casino market and it has three major areas of business. a. Casino's – Company operates casinos in Goa, Sikkim and Daman. They operate 3 offshore casinos in Goa out of a total of 6 offshore casino licenses and also one land-based casino. b. Online Gaming - Adda52.com currently offers online poker games. It currently holds number one position in India. The other website 'Adda52rummy.com' offers online games of Rummy. c. Hospitality - Gaming and hospitality go hand in hand. Both these are mutually inclusive and reciprocating businesses, each driving the other. 3. The company is expanding its regional footprint by starting new casino center at Nepal upon receiving the gaming license in Feb 2020. 4. On Dec 12-2020 The company had received a license to establish a integrated resort consisting of hotels, convention centre, mutliplex cinema, electronic casino, retail area, water park and other facilities at Pernem, Goa. 5. The company owns 34% of Advani Hotels & Resorts Ltd which gives it the same stake in its Caravela Beach Resort situated at Varca Beach, Goa.
NSE:DELTACORPLong
by akashbothra